| 13/07/26 | 07:00:11 | 13 Jul 2026 | | Mid-Year Operational and Corporate Summary |
| 29/06/26 | 12:02:22 | 29 Jun 2026 | | Result of AGM |
| 22/06/26 | 07:00:11 | 22 Jun 2026 | | Participation at BIO International Convention 2026 |
| 17/06/26 | 07:00:06 | 17 Jun 2026 | | Company to present at Animal Longevity Summit 2026 |
| 04/06/26 | 07:00:04 | 4 Jun 2026 | | Notice of AGM |
| 08/05/26 | 10:07:16 | 8 May 2026 | | Exercise of Warrants and Issue of Equity |
| 30/04/26 | 13:12:33 | 30 Apr 2026 | | Final Results |
| 28/04/26 | 07:00:07 | 28 Apr 2026 | | Expansion of Confidentiality Agreements |
| 20/04/26 | 07:00:08 | 20 Apr 2026 | | Strategic Technology Collaboration |
| 13/04/26 | 07:00:09 | 13 Apr 2026 | | International Patent Publication |
| 08/04/26 | 08:55:09 | 8 Apr 2026 | | Update on the Dog Study |
| 31/03/26 | 07:00:01 | 31 Mar 2026 | | Total Voting Rights |
| 05/03/26 | 10:55:27 | 5 Mar 2026 | | Issue of Equity & PDMR Notifications |
| 02/03/26 | 12:30:20 | 2 Mar 2026 | | Result of GM |
| 02/03/26 | 07:00:15 | 2 Mar 2026 | | Receipt of First Tranche of Grant |
| 12/02/26 | 07:00:08 | 12 Feb 2026 | | Preliminary Interim Results From Dog Study |
| 11/02/26 | 07:00:11 | 11 Feb 2026 | | Notice of GM |
| 30/01/26 | 12:29:01 | 30 Jan 2026 | | Holding(s) in Company |
| 28/01/26 | 07:00:09 | 28 Jan 2026 | | Administrative Approval of Grant & 2026 Priorities |
| 19/01/26 | 07:00:06 | 19 Jan 2026 | | Directorate change |
| 08/01/26 | 07:00:09 | 8 Jan 2026 | | Review of 2025 |
| 16/12/25 | 07:00:08 | 16 Dec 2025 | | Completion of Dosing Phase of Canine Gene Therapy |
| 11/12/25 | 07:00:09 | 11 Dec 2025 | | Genflow to Attend Healthcare Conference |
| 31/10/25 | 07:00:03 | 31 Oct 2025 | | Total Voting Rights |
| 24/10/25 | 07:00:12 | 24 Oct 2025 | | Holding(s) in Company |
| 22/10/25 | 07:00:08 | 22 Oct 2025 | | Second European Patent Application |
| 20/10/25 | 07:00:08 | 20 Oct 2025 | | Recognition of Patentability of Claims |
| 10/10/25 | 07:00:08 | 10 Oct 2025 | | Update on Animal Health Program |
| 09/10/25 | 07:00:09 | 9 Oct 2025 | | Update, Equity Issue and PDMR Notification |
| 02/10/25 | 12:37:10 | 2 Oct 2025 | | Issue of Equity - Correction |
| 02/10/25 | 07:59:20 | 2 Oct 2025 | | Issue of Equity |
| 30/09/25 | 07:00:17 | 30 Sept 2025 | | Half-year Report |
| 19/09/25 | 12:40:54 | 19 Sept 2025 | | Holding(s) in Company |
| 19/09/25 | 07:00:16 | 19 Sept 2025 | | Genflow Strengthens IP Portfolio |
| 15/09/25 | 07:00:13 | 15 Sept 2025 | | Genflow Signs CDAs with Animal Health Companies |
| 27/08/25 | 15:07:51 | 27 Aug 2025 | | Holding(s) in Company |
| 18/08/25 | 07:00:09 | 18 Aug 2025 | | Company Update on Dog Trials |
| 24/07/25 | 07:00:12 | 24 Jul 2025 | | Clinical Readiness Acceleration |
| 17/07/25 | 07:00:07 | 17 Jul 2025 | | Genflow Confirms Progression of Grant |
| 17/06/25 | 07:00:10 | 17 Jun 2025 | | Corporate Update |
| 12/06/25 | 10:16:32 | 12 Jun 2025 | | Result of AGM |
| 30/05/25 | 15:20:06 | 30 May 2025 | | Total Voting Rights |
| 28/05/25 | 07:00:07 | 28 May 2025 | | Genflow Signs Master Services Agreement |
| 22/05/25 | 10:51:24 | 22 May 2025 | | AGM Notice |
| 15/05/25 | 07:00:12 | 15 May 2025 | | Key SIRT6 Patent Application |
| 12/05/25 | 10:50:09 | 12 May 2025 | | Holding(s) in Company |
| 09/05/25 | 07:00:05 | 9 May 2025 | | Share Subscription, Director's Dealing and Update |
| 30/04/25 | 15:29:40 | 30 Apr 2025 | | Final Results |
| 14/04/25 | 07:00:12 | 14 Apr 2025 | | Launch of AI-Powered Partnership |
| 10/04/25 | 07:00:14 | 10 Apr 2025 | | Genflow Launches New Development Program |
